Now showing items 1-2 of 2

    • Injectable hybrid hydrogels physically crosslinked based on carrageenan and green graphene for tissue repair 

      Moncada-Villalobos, Danny; Rico, Maite; Montero, Belén; Rodríguez-Llamazares, Saddys; Feijóo-Bandín, Sandra; Gualillo, Oreste; Lago, Francisca; Aragón Herrera, Alana; Salavagione, Horacio; Pettinelli, Natalia; Bouza, Rebeca; Farrag, Yousof (Elsevier, 2023-04)
      [Abstract] Injectable and biocompatible novel hybrid hydrogels based on physically crosslinked natural biopolymers and green graphene for potential use in tissue engineering are reported. Kappa and iota carrageenan, locust ...
    • The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile 

      Aragón Herrera, Alana; Otero-Santiago, Manuel; Anido Varela, Laura; Moraña Fernández, Sandra; Campos-Toimil, Manuel; García-Caballero, Tomas; Barral, Luis; Tarazón, Estefanía; Roselló-Lletí, Esther; Portolés, M; Gualillo, Oreste; Moscoso, Isabel; Lage Fernández, Ricardo; González-Juanatey, J.R.; Feijóo-Bandín, Sandra; Lago, Francisca (Frontiers Media, 2022-01-02)
      [Abstract] The EMPA-REG OUTCOME (Empagliflozin, Cardiovascular Outcome Event Trial in patients with Type 2 Diabetes Mellitus (T2DM)) trial evidenced the potential of sodium-glucose cotransporter 2 (SGLT2) inhibitors for ...